INSM
Insmed Incorporated
$108.87
+$2.63(+2.48%)
41
Overall
40
Value
20
Tech
63
Quality
Market Cap
$35.04B
Volume
2.27M
52W Range
$64.85 - $212.75
Target Price
$203.82
Order:
Income Statement
| Metric | Trend | Chart | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | -- | -- | $9.8M | $136.5M | $164.4M | $188.5M | $245.4M | $305.2M | $363.7M | $606.4M | ||
| Total Revenue | -- | -- | $9.8M | $136.5M | $164.4M | $188.5M | $245.4M | $305.2M | $363.7M | $606.4M | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | -- | -- | $2.4M | $24.2M | $39.9M | $44.2M | $55.1M | $65.6M | $85.7M | $122.9M | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | -- | -- | $7.4M | $112.3M | $124.5M | $144.3M | $190.2M | $239.6M | $278.0M | $483.5M | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $-173.4M | $188.9M | $314.8M | $347.5M | $389.8M | $512.1M | $668.4M | $920.6M | $1.1B | $1.5B | ||
| Research & Development | $122.7M | $109.7M | $145.3M | $131.7M | $181.2M | $272.7M | $397.5M | $571.0M | $598.4M | $771.1M | ||
| Research Expense | $122.7M | $109.7M | $145.3M | $131.7M | $181.2M | $272.7M | $397.5M | $571.0M | $598.4M | $771.1M | ||
| Selling, General & Administrative | $50.7M | $79.2M | $168.2M | $210.8M | $203.6M | $234.3M | $265.8M | $344.5M | $461.1M | $701.2M | ||
| General & Administrative Expenses | $50.7M | $79.2M | $168.2M | $210.8M | $203.6M | $234.3M | $265.8M | $344.5M | $461.1M | $701.2M | ||
| Depreciation & Amortization | $-2.4M | $-2.9M | $1.2M | $5.0M | $5.0M | $5.1M | $5.1M | $5.1M | $5.1M | $6.0M | ||
| Depreciation & Amortization | $-2.4M | $-2.9M | $1.2M | $5.0M | $5.0M | $5.1M | $5.1M | $5.1M | $5.1M | $6.0M | ||
| Amortization | -- | -- | $1.2M | $5.0M | $5.0M | $5.1M | $5.1M | $5.1M | $5.1M | $6.0M | ||
| Other Operating Expenses | -- | -- | $-742.0K | $-809.0K | $-829.0K | $-1.6M | $-2.6M | -- | -- | -- | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $-173.4M | $-188.9M | $-307.3M | $-235.2M | $-265.2M | $-375.1M | $-457.3M | $-709.6M | $-878.3M | $-1.2B | ||
| EBITDA | $-170.0M | $-184.0M | $-276.5M | $-195.9M | $-250.4M | $-383.6M | $-441.4M | $-644.7M | $-804.5M | $-1.2B | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $3.5M | $5.9M | $25.5M | $27.7M | $28.2M | $38.6M | $22.5M | $81.7M | $84.9M | $83.8M | ||
| Intinc | -- | -- | -- | -- | -- | -- | -- | $1.9M | $2.2M | -- | ||
| Net Non-Operating Interest Income/Expense | $-3.5M | $-5.9M | $-25.5M | $-27.7M | $-29.6M | $-40.5M | $-26.4M | $-74.4M | $-84.9M | $-83.8M | ||
| Gain on Sale of Securities | $604.0K | $1.6M | $10.3M | $9.9M | $1.7M | $174.0K | $9.6M | $42.5M | $53.1M | $60.7M | ||
| Other Income/Expense | $-723.0K | $-1.9M | $-8.7M | $-9.4M | $-2.1M | $28.2M | $24.4M | $-15.6M | $38.6M | $193.2M | ||
| Other Special Charges | $119.0K | $300.0K | $-1.6M | $-531.0K | $405.0K | $-21.0M | $-5.9M | $1.9M | $29.0K | $-1.8M | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $-172.7M | $-187.0M | $-298.6M | $-225.9M | $-264.5M | $-397.8M | $-457.7M | $-665.3M | $-825.2M | $-1.2B | ||
| Pre-Tax Income | $-176.2M | $-192.9M | $-324.1M | $-253.6M | $-292.7M | $-436.4M | $-480.2M | $-747.0M | $-910.1M | $-1.3B | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $100.0K | $-272.0K | $201.0K | $777.0K | $1.4M | $-1.8M | $1.4M | $2.6M | $3.7M | $5.0M | ||
| NET INCOME | ||||||||||||
| Net Income | $-176.3M | $-192.6M | $-324.3M | $-254.3M | $-294.1M | $-434.7M | $-481.5M | $-749.6M | $-913.8M | $-1.3B | ||
| Net Income (Continuing Operations) | $-176.3M | $-192.6M | $-324.3M | $-254.3M | $-294.1M | $-434.7M | $-481.5M | $-749.6M | $-913.8M | $-1.3B | ||
| Net Income (Discontinued Operations) | $-176.3M | $-192.6M | $-324.3M | $-254.3M | $-294.1M | $-434.7M | $-481.5M | $-749.6M | $-913.8M | $-1.3B | ||
| Net Income (Common Stockholders) | $-176.3M | $-192.6M | $-324.3M | $-254.3M | $-294.1M | $-434.7M | $-481.5M | $-749.6M | $-913.8M | $-1.3B | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | -- | -- | -- | $-1.0B | ||
| TOTALS | ||||||||||||
| Total Expenses | $-173.4M | $188.9M | $317.2M | $371.7M | $429.6M | $556.2M | $723.5M | $986.1M | $1.2B | $1.6B | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $61.9M | $66.6M | $76.9M | $84.6M | $97.6M | $112.1M | $123.0M | $140.4M | $164.0M | $199.0M | ||
| Average Shares Outstanding (Diluted) | $61.9M | $66.6M | $76.9M | $84.6M | $97.6M | $112.1M | $123.0M | $140.4M | $164.0M | $199.0M | ||
| Shares Outstanding | $124.0M | $153.2M | $155.1M | $179.6M | $103.0M | $118.9M | $136.4M | $148.5M | $181.0M | $215.6M | ||
| Basic EPS | -- | -- | -- | $-3.01 | $-3.01 | $-3.88 | $-3.91 | $-5.34 | $-5.57 | $-6.42 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | $-3.01 | $-3.01 | $-3.88 | $-3.91 | $-5.34 | $-5.57 | $-6.42 | ||
| Diluted EPS | $-2.85 | $-2.89 | $-4.22 | $-3.01 | $-3.01 | $-3.88 | $-3.91 | $-5.34 | $-5.57 | $-6.42 | ||
| Diluted EPS (Continuing Operations) | -- | -- | $-4.22 | -- | -- | $-3.88 | $-3.91 | $-5.34 | $-5.57 | $-6.42 | ||
| OTHER METRICS | ||||||||||||
| Accrued Preferred Stock Dividends | -- | -- | -- | -- | -- | -- | -- | $749.6M | $913.8M | $1.3B | ||
| Other Gand A | $50.7M | $79.2M | $168.2M | $210.8M | $203.6M | $234.3M | $265.8M | $344.5M | $461.1M | $701.2M | ||
| Preferred Stock Dividends | -- | -- | -- | -- | -- | -- | -- | $749.6M | $913.8M | $1.3B | ||
| Rent And Landing Fees | $50.7M | $79.2M | $-2.1M | -- | -- | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | INSM | $108.87 | +2.5% | 2.27M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |